UniProtKB/SwissProt variant VAR

Variant information

Variant position:

157

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

LP/P [Disclaimer]

The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Alanine (A) to Proline (P) at position 157 (A157P, p.Ala157Pro).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Change from small size and hydrophobic (A) to medium size and hydrophobic (P)

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

-1

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Variant description:

In CLN7; due to a deletion-insertion mutation at nucleotide level.

Any additional useful information about the variant.

Sequence information

Variant position:

157

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

518

The length of the canonical sequence.

Location on the sequence:

VARGLLGIGAGNVAVVRSYT A GATSLQERTSSMANISMCQA

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         VARGLLGIGAGNVAVVRSYTAGATSLQERTSSMANISMCQA

Mouse                         IARGLVGFGAGNVAVVRSYIAGATSLQERTNAMANTSTCQA

Xenopus laevis                LARTFVGFGSGNVAVVRSYVAGATSLSERTGAMANISAFQA

Zebrafish                     LARTFVGIGAGNVAVVRSYVAGATSLKERTSAMANMSACQA

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 518	Major facilitator superfamily domain-containing protein 8
Topological domain	153 – 173	Cytoplasmic
Alternative sequence	147 – 184	Missing. In isoform 2.

Literature citations

Mutations in CLN7/MFSD8 are a common cause of variant late-infantile neuronal ceroid lipofuscinosis.
Kousi M.; Siintola E.; Dvorakova L.; Vlaskova H.; Turnbull J.; Topcu M.; Yuksel D.; Gokben S.; Minassian B.A.; Elleder M.; Mole S.E.; Lehesjoki A.-E.;
Brain 132:810-819(2009)
Cited for: VARIANTS CLN7 HIS-139; PRO-157; LYS-294; ASP-310 AND TRP-465;

Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses.
Kousi M.; Lehesjoki A.E.; Mole S.E.;
Hum. Mutat. 33:42-63(2012)
Cited for: VARIANTS CLN7 PRO-157; ASN-160; ILE-160; LYS-458; GLN-465 AND VAL-470;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q8NHS3: Variant p.Ala157Pro